BDNF: Exercise, Memory and the Limits of Blood Testing

“Do intervals, fast and take this supplement: you will raise BDNF and rejuvenate your brain.” The sentence sounds scientific because it includes an acronym. The problem is everything it skips between that acronym and the promise.

BDNF is involved in plasticity, learning and memory, but it is not a clinical thermometer of brain youth. Exercise can change its concentration in blood, while a peripheral value still cannot tell us how much BDNF is acting in your hippocampus or whether you will avoid cognitive decline.

That distinction does not make BDNF less important. It lets us appreciate a fascinating molecule without chasing it as a laboratory target.

What BDNF is and what it does

BDNF stands for brain-derived neurotrophic factor. It belongs to the neurotrophins, a family of proteins involved in development, maintenance and adaptation of the nervous system.

Its signaling in the brain contributes to synaptic plasticity, learning and memory. “Plasticity” means that connections can change with experience. It does not mean that any neuron can regrow or that the whole brain regenerates.

A review by Miranda and colleagues describes a tightly regulated, variable system. Expression changes with region, activity and context. The precursor proBDNF and mature BDNF can also activate different receptors and effects. A test reporting “total BDNF” compresses that complexity into one number.

A 2025 physiological review adds another caution: decades of overexpression experiments created confusion and direct therapeutic successes have so far been limited. An essential pathway is not automatically one we know how to increase precisely, safely and usefully in an individual.

“Brain fertilizer” is a metaphor, not a treatment

The nickname helps us picture a signal supporting maintenance and adaptation. It can also mislead. A plant benefits from more fertilizer up to a point; the nervous system does not follow such a simple rule.

Brain region, cell type, timing, molecular form and receptor all matter. Locally released BDNF during activity is not equivalent to BDNF stored in platelets. Nor is there a universal concentration above which the brain becomes “fertile”.

Change the question. Instead of “how do I raise BDNF?”, ask: which behaviour improves my function, cardiovascular health and capacity to learn at a reasonable cost and risk? Movement, sleep and social activity may all belong in the answer without needing a promise about one molecule.

What exercise proves and what it does not

Exercise is the human intervention most studied in relation to BDNF. A 2025 review included 17 studies and 900 adults aged 55 or older. Walking, running and cycling increased circulating BDNF on average, but the confidence interval was wide and the effect changed with health status, mode, intensity and design.

The network analysis ranked some short, low- or moderate-intensity walking protocols favourably. That ranking does not create a universal prescription: it compares a small, heterogeneous network of protocols, not every possible option. The authors themselves call for more rigorous and standardized studies.

The decisive distinction appears in a review of 12 trials and 994 participants, mainly older women. Exercise produced a moderate increase in BDNF, while the change in MMSE, a brief cognitive test, was small and not significant. The biomarker moved; the measured cognitive outcome did not clearly follow.

This does not make exercise ineffective. Its benefits reach far beyond BDNF: cardiorespiratory fitness, blood pressure, metabolism, mood, sleep, mobility and social connection. Use the guide to VO2 max and aerobic capacity to progress without turning one molecule into the marker of success.

The hippocampus trial, a promising result with limits

In 2011, a randomized trial of 120 older adults compared aerobic training with stretching. After one year, the aerobic group increased anterior hippocampal volume by about 2% and improved spatial memory, while the control group lost volume.

The volume increase was associated with higher serum BDNF. “Associated” matters: the trial did not show that BDNF change caused the improvement or that measuring it could guide training. It did not study the diagnosis or prevention of dementia either.

The useful conclusion is more modest and more robust: the older brain retains a capacity to adapt, and aerobic activity can produce functional and structural changes. You do not need to know your BDNF level to benefit.

Why a blood test has so many limitations

BDNF can be measured in serum or plasma, but they are not synonyms. Platelets store much of peripheral BDNF. They release their contents during clotting, so clotting time, temperature, centrifugation, anticoagulant and residual platelet count can change the value.

A 2026 review of 49 stroke studies found substantial heterogeneity and that relevant pre-analytical parameters were often incompletely reported. It concerns a specific population, but illustrates why comparing laboratories or interpreting a decimal without a protocol is risky.

Recent exercise, time of day, age, health and assay method also matter. And although blood contains BDNF, it does not directly read one brain region. There is currently no accepted clinical range that labels a healthy person as having “low plasticity” or an “old brain”.

What the test reports	What it cannot establish by itself
Concentration in one specimen and method	How much BDNF is acting in the hippocampus
Difference from a laboratory range	Individual memory, plasticity or “brain age”
Change between two blood draws	That an intervention rejuvenated the brain
Exploratory research data	Diagnosis of Alzheimer's disease, depression or another condition

BDNF and Alzheimer's disease: mechanism is not prevention

Observational studies find BDNF differences between groups with and without cognitive impairment. Animal models can also manipulate the pathway in ways that are not available in people. Neither layer turns low BDNF into a diagnosis or a demonstrated cause.

The 2024 Lancet Commission on dementia focuses prevention on modifiable factors across life, including education, hearing, vision, blood pressure, LDL cholesterol, smoking, diabetes, physical inactivity and social isolation. It does not propose measuring or raising BDNF as a clinical strategy.

If symptoms appear, the question is not which supplement raises a protein. Assessment should consider onset, progression, daily independence and treatable contributors. Alzheimer's blood biomarkers such as p-tau217 belong to a different class of test, and even they are not a casual screening check for everyone.

Fasting, diet, sleep and supplements: keep evidence levels separate

Fasting and various compounds can change BDNF-related pathways in animals. The human picture is less tidy. A review of 16 calorie-restriction and fasting studies found five reporting an increase, five a decrease and six no significant BDNF change. Cognitive and long-term effects remain uncertain.

A Mediterranean-style diet, sufficient sleep, learning and relationships are reasonable choices because of their broader health effects. They do not need to be sold as “BDNF boosters”, because that explanation may be incomplete or unproven in humans.

There is no approved BDNF capsule that rejuvenates the brain. A plant extract activating TrkB, changing BDNF in an animal or raising a peripheral value does not establish memory benefit, dementia prevention, a safe dose or lasting benefit in people.

A practical strategy that does not chase the biomarker

1. Build repeatable movement. Combine sustainable aerobic activity with adapted strength work. Muscle health also protects function and independence; the guide to sarcopenia explains why.
2. Track outcomes you can feel or interpret. Walking capacity, strength, blood pressure, sleep, mood and daily function are often more useful than isolated BDNF.
3. Protect recovery. A plan that worsens pain, insomnia or fatigue is not redeemed by an acute molecular spike.
4. Seek help for cognitive change. Progressive memory loss, disorientation, errors with medication or money and difficulty with familiar tasks deserve assessment.

There is no winning intensity for everyone. Start from current health and function, progress gradually and adapt exercise if chest pain, fainting, disproportionate breathlessness or new neurological symptoms occur.

Marketing signals that should make you pause

• a BDNF test diagnosing brain age without a validated clinical range;
• a promise to prevent Alzheimer's disease by raising a peripheral value;
• an exact improvement percentage without specimen, timing and assay;
• rodent results presented as human treatment;
• a test leading directly to a supplement or programme sold by the same provider;
• a variant such as Val66Met used to claim that a form of exercise cannot work for you.

A serious explanation can recognize that BDNF matters while admitting that it is not yet a personal clinical target. That combination of curiosity and restraint is good science, not pessimism.

Frequently asked questions about BDNF

What is BDNF?

BDNF is a protein in the neurotrophin family. It is involved in neuronal survival and adaptation, synaptic plasticity, learning and memory. It is one part of a broad biological network, not a single measure of brain health.

Why is BDNF called brain fertilizer?

It is a metaphor for its role in plasticity and neuronal maintenance. It can help explain the concept, but it oversimplifies: effects depend on location, timing, receptor and the form of BDNF. More BDNF in blood does not automatically mean a better brain.

Does exercise increase BDNF?

On average, aerobic exercise can increase circulating BDNF acutely and after training programmes, although studies are heterogeneous. Walking, running and cycling do not have a universal BDNF dose, and raising it does not by itself establish cognitive improvement.

Does more BDNF improve memory?

A linear relationship cannot be assumed. One exercise trial found hippocampal-volume and memory changes associated with serum BDNF, while a review in older people found higher BDNF without a significant MMSE improvement. A biomarker and a clinical outcome are not the same.

Can BDNF be measured in blood?

Yes, in serum or plasma, but the measures are not interchangeable. Platelets store substantial BDNF, and clotting, transport, centrifugation, recent exercise and the assay alter results. There is no validated threshold for diagnosing brain aging in a healthy person.

Does low BDNF mean Alzheimer's disease?

No. BDNF differences have been observed between groups with neurological or psychiatric conditions, but there is overlap, multiple causes and measurement difficulty. A low value neither diagnoses Alzheimer's disease nor calculates individual risk, and it cannot replace clinical assessment.

Do fasting or supplements increase BDNF?

Human fasting evidence conflicts: one review found studies reporting increases, decreases and no change. There is no validated BDNF supplement that rejuvenates the brain. A molecular claim is not enough to demonstrate memory benefit, prevention or safety.

What should I do if I notice memory changes?

Do not try to correct presumed low BDNF. Seek assessment when a change is new, progressive or affects daily life. History, medication, mood, sleep, hearing, vision, vascular health and cognitive testing should be reviewed before deciding whether specific investigations are needed.

Sources

1. Miranda M et al. BDNF in the healthy and pathological brain. Frontiers in Cellular Neuroscience. 2019.
2. Scharfman HE et al. The physiopathology of BDNF. Physiological Reviews. 2025.
3. Cheng Y et al. Aerobic exercise and circulating BDNF in older adults. Frontiers in Aging Neuroscience. 2025.
4. Farrukh S et al. Exercise, BDNF and cognition in older people. Archives of Gerontology and Geriatrics. 2023.
5. Erickson KI et al. Exercise, hippocampal volume and memory. PNAS. 2011.
6. Bevilacqua E et al. Pre-analytical variables in BDNF measurement. Clinical Chemistry and Laboratory Medicine. 2026.
7. Mirzaei K et al. Fasting, BDNF and cognition in humans. Medicina. 2024.
8. Livingston G et al. Dementia prevention, intervention and care. The Lancet. 2024.

Method: narrative review of the linked reviews, meta-analyses and trial. Mechanism, peripheral biomarker and clinical outcome are separated; BDNF changes are not presented as dementia prevention. Sources checked 29 August 2026. This article is educational and does not replace medical assessment.

Commercial disclosure: Progevita offers health assessment and exercise guidance. That does not make BDNF a routine test or mean that one value justifies purchasing a programme or supplement.